A combined genomic arrhythmia propensity score delineates cumulative risk

85

A combined genomic arrhythmia propensity score delineates cumulative risk

Tags:

Previous Article

ALS treatment using RNA-based gene therapy

Genetic testing trifecta predicts risk of sudden cardiac death and arrhythmia

Related Posts

Trehalose 6-phosphate: A master regulator of plant development

Trehalose 6-phosphate: A master regulator of plant deve...

72

Renin–angiotensin system: a novel target for brain health

Renin–angiotensin system: a novel target for brain health

584

Adipose tissue-targeting nanomedicines for obesity pharmacotherapy

Adipose tissue-targeting nanomedicines for obesity phar...

125